Isometric Handgrip Training Frequency and Blood Pressure in People With Hypertension
The Dose Response Effect of Isometric Handgrip Training Frequency on Blood Pressure and Vascular Health in People With Hypertension: A Randomised Controlled Trial
1 other identifier
interventional
45
1 country
1
Brief Summary
Hypertension is the most important cause of cardiovascular disease (CVD), stroke, and premature death (WHO, 2021). It is estimated by The World Health Organisation in 2021 that 1.4 billion individuals across the globe have high blood pressure, with only 14% of people actively managing these elevated levels. Simple and effective lifestyle strategies are required to help people improve their blood pressure and/or attenuate increases in blood pressure with ageing. Physical activity is one possible strategy: in previous research, several different types of physical activity have been shown to have beneficial effects on blood pressure (Blackwell et al., 2017). However, many individuals do not adhere to currently recommended levels of physical activity (150 mins of moderate intensity physical activity per week), due to a combination of the required time commitment, lack of motivation, and the associated levels of effort, exertion, and physical discomfort (Korkiakangas et al 2009). Thus, there is a need to identify alternative exercise interventions which will overcome these barriers but remain effective at improving blood pressure (Herrod, Lund, \& Phillips, 2021, Toohey et al, 2018). Low intensity isometric hand grip exercise training (IET) has been shown to result in large decreases in resting blood pressure in younger and older age groups, in both men and women, and in individuals with normal as well as elevated baseline blood pressure (Badrov et al, 2013; Bentley et al., 2018; Millar et al., 2014). In this research, IET has almost universally involved performing 4 x 2 IET holds at 30% of maximal voluntary contraction, 3 times a week, over a 4-8-week intervention (Millar et al, 2014). There are very few studies that have investigated the effect of changing different protocol parameters on changes in blood pressure and vascular health, and the minimal effective dose of IET is unknown. Defining the minimal effective dose of different types of exercise may help overcome key barriers to exercise by lowering the required time commitment, reducing perceived effort/exertion, and promoting more positive affective responses. One important modifiable parameter is training frequency and it is unknown whether reducing the frequency of IET will reduce the efficacy for improving blood pressure. Therefore, the primary objective of this study is to determine if reducing the frequency of isometric handgrip training from four times a week to two times a week will affect the improvements in resting blood pressure and vascular health in people with hypertension. A secondary objective is to investigate the acute affective and perceptual responses to sessions of IET and the effect of training on these acute affective/perceptual responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Mar 2024
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2024
CompletedFirst Submitted
Initial submission to the registry
March 21, 2024
CompletedFirst Posted
Study publicly available on registry
March 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
July 6, 2026
July 1, 2026
4 years
March 21, 2024
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Office measured supine and seated systolic, diastolic and mean arterial pressure
Office measured supine and seated systolic, diastolic and mean arterial pressure will be measured at baseline and 3 days following the final exercise session
6 weeks
Secondary Outcomes (7)
Office measured central systolic, diastolic and mean arterial pressure
6 weeks
24-h mean ambulatory systolic, diastolic, and mean arterial pressure
6 weeks
Daytime ambulatory systolic, diastolic, and mean arterial pressure
6 weeks
Sleeping ambulatory systolic, diastolic and mean arterial pressure
6 weeks
Carotid-Femoral Pulse Wave Velocity
6 weeks
- +2 more secondary outcomes
Study Arms (3)
No Intervention Control
NO INTERVENTIONParticipants will be asked to maintain their normal lifestyle patterns (i.e. diet and physical activity) and will undergo no other intervention.
Two Sessions/Week
EXPERIMENTALParticipants will complete 6-weeks of supervised isometric handgrip exercise training with a frequency of two sessions/week
Four Sessions/Week
EXPERIMENTALParticipants will complete 6-weeks of supervised isometric handgrip exercise training with a frequency of four sessions/week
Interventions
Participants allocated to the exercise groups will complete 6 weeks of isometric handgrip exercise training (IHGT) using an electronic hand dynamometer (Camry EH101, Zhongshan Camry Electronic Co. Ltd, Guangdong) for either 2 or 4 sessions per week. Each exercise session will consist of 4 x 2-minute isometric contractions at 30% MVC with 1 minute rest periods between contractions. The first bout will be performed on the dominant arm and then the arm will be alternated for each subsequent two-minute bout. Participants will be instructed to try keep the contraction tension as close as possible to the set tension of 30% MVC using visual feedback from the dynamometer's electronic display.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65 years.
- Scoring low or moderate on the international physical activity questionnaire (IPAQ).
- Previous diagnosis of high blood pressure and/or a resting systolic blood pressure ≥130 but \<180 mmHg (self-reported and confirmed during screening/baseline assessment).
- Currently taking no anti-hypertensive medicine or taking anti-hypertensive medicine with no treatment change within the last 4 months prior to enrollment.
- Stable dietary and physical activity patterns (including dietary supplementation) over the last 4 months
You may not qualify if:
- Aged \<18 or \>65 years
- Resting blood pressure ≥180/110 mmHg or resting heart rate \>100 bpm during baseline as-sessment
- Manifest cardiovascular disease including cerebrovascular disease, heart failure, chronic kidney disease, peripheral vascular disease, or advanced retinopathy (fundus hypertonicus grades III-IV) based on a self-report health history questionnaire.
- Type 1 diabetes
- History of other chronic disease including malignancy, neurological conditions (e.g. multiple sclerosis) or respiratory conditions (e.g. COPD).
- Contraindications to exercise based on answers to the physical activity readiness questionnaire.
- Physical limitations preventing handgrip exercise (e.g. arthritis or other musculoskeletal disorder)
- Scoring "high" on the international physical activity questionnaire
- Taking more than 2 anti-hypertensive drugs or a change in treatment strategy in the previous 4 months.
- Currently taking nitrate medication (as it is commonly prescribed for angina) or on hormone replacement therapy
- Significant self-reported change in lifestyle patterns in the prior 4 months (e.g. currently on a planned diet for weight loss).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Swansea University
Swansea, Wales, SA18EN, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Metcalfe, PhD
Swansea University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2024
First Posted
March 28, 2024
Study Start
March 20, 2024
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
July 6, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share